Heat-directed tumor cell fusion

Human Gene Therapy

Volumn 14, Issue 5, 2003, Pages 447-461

  Brade, Anthony M ^a,b   Szmitko, Paul ^a,b   Ngo, Duc ^a,b   Liu, Fei Fei ^a,b   Klamut, Henry J ^a,b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; VIRUS PROTEIN;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL FUSION; CELL LINE; CONTROLLED STUDY; FOOT PAD; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GIBBON LEUKEMIA VIRUS; HEAT TREATMENT; HELA CELL; HUMAN; HUMAN CELL; HYPERTHERMIA; IMMUNE DEFICIENCY; PROMOTER REGION; PROTEIN EXPRESSION; SURVIVAL; SYNCYTIUM; THERMODYNAMICS; TUMOR CELL; TUMOR NECROSIS; TUMOR XENOGRAFT;

ADENOVIRIDAE; ANIMALS; CELL FUSION; CELL SURVIVAL; DEFECTIVE VIRUSES; FEMALE; GENE PRODUCTS, ENV; GENETIC VECTORS; HEAT; HSP70 HEAT-SHOCK PROTEINS; HUMANS; LEUKEMIA VIRUS, GIBBON APE; MICE; MICE, SCID; MODELS, ANIMAL; NEOPLASMS, EXPERIMENTAL; PLASMIDS; REMISSION INDUCTION; TRANSFECTION; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

ALOCASIA MACRORRHIZOS; GIBBON APE LEUKEMIA VIRUS; HYLOBATES SP.;

EID: 0037457016     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303403321467216     Document Type: Article

References (52)

1. BATEMAN, A., BULLOUGH, F., MURPHY, S., EMILIUSEN, L., LAVILLETTE, D., COSSET, F.L., CATTANEO, R., RUSSELL, S.J., and VILE, R.G. (2000). Fusogenic membrane glycoproteins as a novel class of genes for the local and immune-mediated control of tumor growth [erratum appears in Cancer Res 2000;60:4978]. Cancer Res. 60, 1492-1497.
2. BLACKBURN, R.V., GALOFORO, S.S., CORRY, P.M., and LEE, Y.J. (1998). Adenoviral-mediated transfer of a heat-inducible double suicide gene into prostate carcinoma cells. Cancer Res. 58, 1358-1362.
3. BLACKBURN, R.V., GALOFORO, S.S., CORRY, P.M., and LEE, Y.J. (1999). Adenoviral transduction of a cytosine deaminase/thymidine kinase fusion gene into prostate carcinoma cells enhances prodrug and radiation sensitivity. Int. J. Cancer 82, 293-297.
4. BORRELLI, M.J., SCHOENHERR, D.M., WONG, A., BERNOCK, L.J., and CORRY, P.M. (2001). Heat-activated transgene expression from adenovirus vectors infected into human prostate cancer cells. Cancer Res. 61, 1113-1121.
5. BOTZLER, C., LI, G., ISSELS, R.D., and MULTHOFF, G. (1998). Definition of extracellular localized epitopes of Hsp70 involved in an NK immune response. Cell Stress Chaperones 3, 6-11.
6. BRADE, A.M., NGO, D., SZMITKO, P., LI, P.X., LIU, F.F., and KLAMUT, H.J. (2000). Heat-directed gene targeting of adenoviral vectors to tumor cells. Cancer Gene Ther. 7, 1566-1574.
7. BRAIDEN, V., OHTSURU, A., KAWASHITA, Y., MIKI, F., SAWADA, T., ITO, M., CAO, Y., KANEDA, Y., KOJI, T., and YAMASHITA, S. (2000). Eradication of breast cancer xenografts by hyperthermic suicide gene therapy under the control of the heat shock protein promoter. Hum. Gene Ther. 11, 2453-2463.
8. DENNING, C., and PITTS, J.D. (1997). Bystander effects of different enzyme-prodrug systems for cancer gene therapy depend on different pathways for intercellular transfer of toxic metabolites, a factor that will govern clinical choice of appropriate regimes. Hum. Gene Ther. 8, 1825-1835.
9. DIAZ, R.M, BATEMAN, A., EMILIUSEN, L., FIELDING, A., TRONO, D., RUSSELL, S.J., and VILE, R.G. (2000). A lentiviral vector expressing a fusogenic glycoprotein for cancer gene therapy. Gene Ther. 7, 1656-1663.
10. EMILIUSEN, L., GOUGH, M., BATEMAN, A., AHMED, A., VOELLMY, R., CHESTER, J., DIAZ, R.M., HARRINGTON, K., and VILE, R. (2001). A transcriptional feedback loop for tissue-specific expression of highly cytotoxic genes which incorporates an immunostimulatory component. Gene Ther. 8, 987-998.
11. FREEMAN, S.M., ABBOUD, C.N., WHARTENBY, K.A., PACKMAN, C.H., KOEPLIN, D.S., MOOLTEN, F.L., and ABRAHAM, G.N. (1993). The "bystander effect": Tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res. 53, 5274-5283.
12. FREEMAN, S.M., WHARTENBY, K.A., FREEMAN, J.L., ABBOUD, C.N., and MARROGI, A.J. (1996). In situ use of suicide genes for cancer therapy [review]. Semin. Oncol. 23, 31-45.
13. FREYTAG, S.O., ROGULSKI, K.R., PAIELLI, D.L., GILBERT, J.D., and KIM, J.H. (1998). A novel three-pronged approach to kill cancer cells selectively: Concomitant viral, double suicide gene, and radiotherapy [see comments]. Hum. Gene Ther. 9, 1323-1333.
14. GALANIS, E., BATEMAN, A., JOHNSON, K., DIAZ, R.M., JAMES, C.D., VILE, R., and RUSSELL, S.J. (2001). Use of vital fusogenic membrane glycoproteins as novel therapeutic transgenes in gliomas. Hum. Gene Ther. 12, 811-821.
15. GERNER, E.W., HERSH, E.M., PENNINGTON, M., TSANG, T.C., HARRIS, D., VASANWALA, F., and BRAILEY, J. (2000). Heat-inducible vectors for use in gene therapy. Int. J. Hyperthermia 16, 171-181.
16. GLOTZER, J.B., SALTIK, M., CHIOCCA, S., MICHOU, A.I., MOSELEY, P., and COTTEN, M. (2000). Activation of heat-shock response by an adenovirus is essential for virus replication. Nature 407, 207-211.
17. GRAHAM, F.L., and PREVEC, L. (1992). Adenovirus-based expression vectors and recombinant vaccines [review]. Biotechnology 20, 363-390.
18. GRAY, R. (1988). A Class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann. Statistics 16, 1141-1154.
19. GROH, V., STEINLE, A., BAUER, S., and SPIES, T. (1998). Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells. Science 279, 1737-1740.
20. HIGUCHI, H., BRONK, S.F., BATEMAN, A., HARRINGTON, K., VILE, R.G., and GORES, G.J. (2000). Viral fusogenic membrane glycoprotein expression causes syncytia formation with bioenergetic cell death: Implications for gene therapy. Cancer Res. 60, 6396-6402.
21. HOGANSON, D.K., BATRA, R.K., OLSEN, J.C., and BOUCHER, R.C. (1996). Comparison of the effects of three different toxin genes and their levels of expression on cell growth and bystander effect in lung adenocarcinoma. Cancer Res. 56, 1315-1323.
22. HUANG, Q., HU, J.K., LOHR, F., ZHANG, L., BRAUN, R., LANZEN, J., LITTLE, J.B., DEWHIRST, M.W., and LI, C.Y. (2000). Heat-induced gene expression as a novel targeted cancer gene therapy strategy. Cancer Res. 60, 3435-3439.
23. JACKSON, R.J., HOWELL, M.T., and KAMINSKI, A. (1990). The novel mechanism of initiation of picornavirus RNA translation. Trends Biochem. Sci. 15, 477-483.
24. JANG, S.K., PESTOVA, T.V., HELLEN, C.U., WITHERELL, G.W., and WIMMER, E. (1990). Cap-independent translation of picornavirus RNAs: structure and function of the internal ribosomal entry site. Enzyme 44, 292-309.
25. JANICKE, R.U., ENGELS, I.H., DUNKERN, T., KAINA, B., SCHULZE-OSTHOFF, K., and PORTER, A.G. (2001). Ionizing radiation but not anticancer drugs causes cell cycle arrest and failure to activate the mitochondrial death pathway in MCF-7 breast carcinoma cells. Oncogene 20, 5043-5053.
26. JAROSZESKI, M.J., GILBERT, R., and HELLER, R. (1994). Detection and quantitation of cell-cell electrofusion products by flow cytometry. Anal. Biochem. 216, 271-275.
27. JOHANN, S.V., GIBBONS, J.J., and O'HARA, B. (1992). GLVR1, a receptor for gibbon ape leukemia virus, is homologous to a phosphate permease of Neurospora crassa and is expressed at high levels in the brain and thymus. J. Virol. 66, 1635-1640.
28. KATAYOSE, D., GUDAS, J., NGUYEN, H., SRIVASTAVA, S., COWAN, K.H., and SETH, P. (1995). Cytotoxic effects of adenovirus-mediated wild-type p53 protein expression in normal and tumor mammary epithelial cells. Clin. Cancer Res. 1, 889-897.
29. KAVANAUGH, M.P., and KABAT, D. (1996). Identification and characterization of a widely expressed phosphate transporter/retrovirus receptor family. Kidney Int. 49, 959-963.
30. KIM, J.H., KOLOZSVARY, A., ROGULSKI, K., KHIL, M.S., BROWN, S.L., and FREYTAG, S.O. (1998). Selective radiosensitization of 9L glioma in the brain transduced with double suicide fusion gene [see comments]. Cancer J. Sci. Am. 4, 364-369.
31. KURIHARA, T., BROUGH, D.E., KOVESDI, I., and KUFE, D.W. (2000). Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUCI antigen. J. Clin. Invest. 106, 763-771.
32. LEE, Y.J., GALOFORO, S.S., BATTLE, P., LEE, H., CORRY, P.M., and JESSUP, J.M. (2001). Replicating adenoviral vector-mediated transfer of a heat-inducible double suicide gene for gene therapy. Cancer Gene Ther. 8, 397-404.
33. LEE, Y.J., LEE, H., and BORRELLI, M.J. (2002). Gene transfer into human prostate adenocarcinoma cells with an adenoviral vector: Hyperthermia enhances a double suicide gene expression, cytotoxicity and radiotoxicity. Cancer Gene Ther. 9, 267-274.
34. LI, P., BUI, T., GRAY, D., and KLAMUT, H.J. (1998). Therapeutic potential of recombinant p53 overexpression in breast cancer cells expressing endogenous wild-type p53. Breast Cancer Res. Treat. 48, 273-286.
35. LI, P.X., NGO, D., BRADE, A.M., and KLAMUT, H.J. (1999). Differential chemosensitivity of breast cancer cells to ganciclovir treatment following adenovirus-mediated herpes simplex virus thymidine kinase gene transfer. Cancer Gene Ther. 6, 179-190.
36. LINDQUIST, S., and CRAIG, E.A. (1988). The heat-shock proteins. Annu. Rev. Genet. 22, 631-677.
37. MA, N., JIN, J., LU, F., WOODGETT, J., and LIU, F.F. (2001). The role of protein kinase B (PKB) in modulating heat sensitivity in a human breast cancer cell line. Int. J. Radiat. Oncol. Biol. Phys. 50, 1041-1050.
38. MATSUBARA, S., WADA, Y., GARDNER, T.A., EGAWA, M., PARK, M.S., HSIEH, C.L., ZHAU, H.E., KAO, C., KAMIDONO, S., GILLENWATER, J.Y., and CHUNG, L.W. (2001). A conditional replication-competent adenoviral vector, Ad-OC-E1a, to cotarget prostate cancer and bone stroma in an experimental model of androgen-independent prostate cancer bone metastasis. Cancer Res. 61, 6012-6019.
39. MELCHER, A., MURPHY, S., and VILE, R. (1999). Heat shock protein expression in target cells infected with low levels of replication-competent virus contributes to the immunogenicity of adenoviral vectors. Hum. Gene Ther. 10, 1431-1442.
40. MULE, J.J., JICHA, D.L., and ROSENBERG, S.A. (1992). The use of congenitally immunodeficient mice to study human tumor metastases and immunotherapy. J. Immunother. 12, 196-198.
41. PALMER, G., MANEN, D., BONJOUR, J.P., and CAVERZASIO, J. (1999). Characterization of the human Glvr-1 phosphate transporter/retrovirus receptor gene and promoter region. Gene 226, 25-33.
42. POPE, I.M., POSTON, G.J., and KINSELLA, A.R. (1997). The role of the bystander effect in suicide gene therapy [review]. Eur. J. Cancer 33, 1005-1016.
43. ROGULSKI, K.R., WING, M.S., PAIELLI, D.L., GILBERT, J.D., KIM, J.H., and FREYTAG, S.O. (2000). Double suicide gene therapy augments the antitumor activity of a replication-competent lytic adenovirus through enhanced cytotoxicity and radiosensitization. Hum. Gene Ther. 11, 67-76.
44. SOUTHERN, E.M. (1975). Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 98, 503-517.
45. SRIVASTAVA, P.K., and AMATO, R.J. (2001). Heat shock proteins: The 'Swiss Army Knife' vaccines against cancers and infectious agents. Vaccine 19, 2590-2597.
46. STEINLE, A., LI, P., MORRIS, D.L., GROH, V., LANIER, L.L., STRONG, R.K., and SPIES, T. (2001). Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family. Immunogenetics 53, 279-287.
47. TENNYSON, C.N., KLAMUT, H.J., and WORTON, R.G. (1995). The human dystrophin gene requires 16 hours to be transcribed and is cotranscriptionally spliced. Nat. Genet. 9, 184-190.
48. VEKRIS, A., MAURANGE, C., MOONEN, C., MAZURIER, F., DE VERNEUIL, H., CANIONI, P., and VOISIN, P. (2000). Control of transgene expression using local hyperthermia in combination with a heat-sensitive promoter. J. Gene Med. 2, 89-96.
49. VILE, R.G., RUSSELL, S.J., and LEMOINE, N.R. (2000). Cancer gene therapy: hard lessons and new courses. Gene Ther. 7, 2-8.
50. WILLIAMS, S.S., ALOSCO, T.R., CROY, B.A., and BANKERT, R.B. (1993). The study of human neoplastic disease in severe combined immunodeficient mice. Lab. Anim. Sci. 43, 139-146.
51. WUST, P., HILDEBRANDT, B., SREENIVASA, G., RAU, B., GELLERMANN, J., RIESS, H., FELIX, R., and SCHLAG, P. (2002). Hyperthermia in combined treatment of cancer. Lancet Oncol. 3, 487-497.
52. XIE, Y., GILBERT, J.D., KIM, J.H., and FREYTAG, S.O. (1999). Efficacy of adenovirus-mediated CD/5-FC and HSV-1 thymidine kinase/ganciclovir suicide gene therapies concomitant with p53 gene therapy. Clin. Cancer Res. 5, 4224-4232.